Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

PLERIXAFOR

PLERIXAFOR

Standard Dose
24MG/1.2ML (20MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PLERIXAFOR is listed in Drugs@FDA under application 217560 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PLERIXAFOR Form and strength SOLUTION;SUBCUTANEOUS - 24MG/1.2ML (20MG/ML) Sponsor HETERO LABS LTD VI Submission history Latest submission status date: 2025-06-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview PLERIXAFOR is listed in Drugs@FDA under application 217560 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PLERIXAFOR Form and strength SOLUTION;SUBCUTANEOUS - 24MG/1.2ML (20MG/ML) Sponsor HETERO LABS LTD VI Submission history Latest submission status date: 2025-06-16 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.